• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Bristol Myers pulls lymphoma indication for Istodax after confirmatory trial falls flat

cafead

Administrator
Staff member
  • cafead   Aug 02, 2021 at 10:32: PM
via Amid an industrywide review of cancer drugs with accelerated approval, Bristol Myers Squibb had to make the tough call last month to yank an approval for leading I/O drug Opdivo after flopping a confirmatory study. Now, a second Bristol Myers drug is on the chopping block.

article source
 

<